Stockreport

What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Heplisav-B's robust U.S. market share and growth trajectory alone justify the acquisition price, and the early-stage pipeline projects offer significant long-term upsid [Read more]